Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ubidecarenone by BPGbio for Sarcopenia: Likelihood of Approval
Ubidecarenone is under clinical development by BPGbio and currently in Phase I for Sarcopenia. According to GlobalData, Phase I drugs...
Data Insights
Ubidecarenone by BPGbio for Glioblastoma Multiforme (GBM): Likelihood of Approval
Ubidecarenone is under clinical development by BPGbio and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...